Assessment of Adherence to Imatinib and Health-Related Quality of Life Among Patients with Gastrointestinal Stromal Tumor: A Cross-Sectional Study in an Oncology Clinic in Malaysia
Paik Ling Chuah,1 Nurnina Fareeha Jamal,1 Chai Jin Siew,1 Ros Suzanna Ahmad Bustamam,2 Vaishnavi Jeyasingam,2 Khei Choong Khong3 1Department of Pharmacy, Kuala Lumpur Hospital, Ministry of Health, Kuala Lumpur, Malaysia; 2Department of Radiotherapy and Oncology, Kuala Lumpur Hospital, Ministry of He...
Main Authors: | Chuah PL, Jamal NF, Siew CJ, Ahmad Bustamam RS, Jeyasingam V, Khong KC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-09-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/assessment-of-adherence-to-imatinib-and-health-related-quality-of-life-peer-reviewed-fulltext-article-PPA |
Similar Items
-
Safety of Regular-Dose Imatinib Therapy in Patients with Gastrointestinal Stromal Tumors Undergoing Dialysis
by: Ryota Niikura, et al.
Published: (2016-05-01) -
Imatinib Mesylate Therapy in Advanced Gastrointestinal Stromal Tumors: Experience from a Single Institute
by: Hui-Hua Hsiao, et al.
Published: (2006-12-01) -
Imatinib-Resistant Gastrointestinal Stromal Tumor Presenting as a Large Abdominal Mass
by: Asim Haider, et al.
Published: (2021-08-01) -
Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
by: Shang-Yu Wang, et al.
Published: (2019-03-01) -
Surgical intervention of a giant gastric gastrointestinal stromal tumor following neoadjuvant therapy with imatinib
by: Chien-Yang Wang, et al.
Published: (2018-01-01)